Evidence map›Paper›PMID 31135052›Full record

ArticleBrain : a journal of neurology2019

FAHN/SPG35: a narrow phenotypic spectrum across disease classifications.

Tim W Rattay, Tobias Lindig, Jonathan Baets, Katrien Smets, Tine Deconinck, Anne S Söhn, Konstanze Hörtnagel, Kathrin N Eckstein, Sarah Wiethoff, Jennifer Reichbauer and 20 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Clinical, Radiological, and Genetic Profile of Patients withTremor and other hyperkinetic movements (New York, N.Y.) · 2026
    Review
  4. Review
  5. Human genetic defects of sphingolipid synthesis.Journal of inherited metabolic disease · 2025
    Review
  6. Disorders of fatty acid homeostasis.Journal of inherited metabolic disease · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. The first reports of FA2H-associated neurodegeneration from two unrelated Iranian families.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Article
  13. Article
  14. Parkinsonism in complex neurogenetic disorders: lessons from hereditary dementias, adult-onset ataxias and spastic paraplegias.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 19 institutions in 7 countries.

Tim W RattayDepartment of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, and Center for Neurology, University of Tübingen, Tübingen, Germany.
Tobias LindigDepartment of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, Tübingen, Germany.
Jonathan BaetsNeurogenetics Group, University of Antwerp, Antwerp, Belgium.
Katrien SmetsNeurogenetics Group, University of Antwerp, Antwerp, Belgium.
Tine DeconinckNeurogenetics Group, University of Antwerp, Antwerp, Belgium.
Anne S SöhnDepartment of Medical Genetics, Institute of Human Genetics, University of Tübingen, Tübingen, Germany.
Konstanze HörtnagelCeGaT GmbH, Tübingen, Germany.
Kathrin N EcksteinDepartment of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, and Center for Neurology, University of Tübingen, Tübingen, Germany.
Sarah WiethoffDepartment of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, and Center for Neurology, University of Tübingen, Tübingen, Germany.
Jennifer ReichbauerDepartment of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, and Center for Neurology, University of Tübingen, Tübingen, Germany.
Marion Döbler-NeumannDepartment of Pediatric Neurology, University Children's Hospital, Tübingen, Germany.
Ingeborg Krägeloh-MannDepartment of Pediatric Neurology, University Children's Hospital, Tübingen, Germany.
Michaela Auer-GrumbachDepartment of Orthopaedics and Trauma-Surgery, Medical University Vienna, Vienna, Austria.
Barbara PleckoDivision of Child Neurology, University Childrens Hospital Zurich, Zurich, Switzerland.
Alexander MünchauDepartment of Pediatric and Adult Movement Disorders and Neuropsychiatry, Institute of Neurogenetics, University of Lübeck, Germany.
Bernd WilkenDepartment of Neuropediatrics, Klinikum Kassel, Germany.
Marc JanauschekDepartment for Social Pediatrics, Kinderhospital Osnabrück, Germany.
Anne-Katrin GieseDepartment of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Jan L De BleeckerDepartment of Neurology, University Hospital Ghent, Ghent, Belgium.
Els OrtibusDepartment of Development and Regeneration, KU Leuven, Leuven, Belgium.
Martine DebyserDepartment of Pediatrics, University Hospitals Leuven, Leuven, Belgium.
Adolfo Lopez de MunainCIBERNED, Center for Networked Biomedical Research into Neurodegenerative Diseases, Madrid, Spain.
Aurora PujolNeurometabolic Diseases Laboratory, Institut d'Investigació Biomedica de Bellvitge IDIBELL, Hospital Duran i Reynals, Barcelona, 08908, Spain.
Maria Teresa BassiScientific Institute IRCCS E. Medea, Laboratory of Molecular Biology, 23842 Bosisio Parini, Lecco, Italy.
Maria Grazia D'AngeloScientific Institute IRCCS E. Medea, Neuromuscular Unit, 23842 Bosisio Parini , Lecco, Italy.
Peter De JongheNeurogenetics Group, University of Antwerp, Antwerp, Belgium.
Stephan ZüchnerJohn P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, FL33136 Miami, USA.
Peter BauerDepartment of Medical Genetics, Institute of Human Genetics, University of Tübingen, Tübingen, Germany.
Ludger SchölsDepartment of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, and Center for Neurology, University of Tübingen, Tübingen, Germany.
Rebecca SchüleDepartment of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, and Center for Neurology, University of Tübingen, Tübingen, Germany.
German Center for Neurodegenerative Diseases · DEUniversity of Antwerp · BEIRCCS Eugenio Medea · ITKU Leuven · BEUniversity Children's Hospital Tübingen · DEBiomedical Research Networking Center on Neurodegenerative Diseases · ESCeGaT (Germany) · DECentogene (Germany) · DEGhent University Hospital · BEHarvard University · USHertie Institute for Clinical Brain Research · DEInstitució Catalana de Recerca i Estudis Avançats · ESKlinikum Kassel · DEMarienhospital Osnabrück · DEMedical University of Vienna · ATUniversity Children's Hospital Zurich · CHUniversity of Lübeck · DEUniversity of Miami · USUniversity of Tübingen · DE

Funding

trainingU54NS065712 · NINDS · WAYNE STATE UNIVERSITY · PI SHY, MICHAEL E. · 2009 to 2023
$19.6M
GENOME STUDIES IN HEREDITARY SPASTIC PARAPLEGIA - beyond the exomeR01NS072248 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Stephan Zuchner · 2011 to 2026
$9.2M
Genomic Studies in Charcot-Marie-Tooth DiseaseR01NS075764 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SHY, MICHAEL E., ZUCHNER, STEPHAN · 2012 to 2016
$3.0M
Molecular And Genetic Analysis Of Autosomal Dominant Spastic ParaplegiaR01NS054132 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ZUCHNER, STEPHAN · 2008 to 2011
$1.3M
Austrian Science Fund FWF P 27634NINDS NIH HHS R01 NS054132NINDS NIH HHS R01 NS072248NINDS NIH HHS R01 NS075764NINDS NIH HHS U54 NS065712
6 · The paper itself

Abstract

The endoplasmic reticulum enzyme fatty acid 2-hydroxylase (FA2H) plays a major role in the formation of 2-hydroxy glycosphingolipids, main components of myelin. FA2H deficiency in mice leads to severe central demyelination and axon loss. In humans it has been associated with phenotypes from the neurodegeneration with brain iron accumulation (fatty acid hydroxylase-associated neurodegeneration, FAHN), hereditary spastic paraplegia (HSP type SPG35) and leukodystrophy (leukodystrophy with spasticity and dystonia) spectrum. We performed an in-depth clinical and retrospective neurophysiological and imaging study in a cohort of 19 cases with biallelic FA2H mutations. FAHN/SPG35 manifests with early childhood onset predominantly lower limb spastic tetraparesis and truncal instability, dysarthria, dysphagia, cerebellar ataxia, and cognitive deficits, often accompanied by exotropia and movement disorders. The disease is rapidly progressive with loss of ambulation after a median of 7 years after disease onset and demonstrates little interindividual variability. The hair of FAHN/SPG35 patients shows a bristle-like appearance; scanning electron microscopy of patient hair shafts reveals deformities (longitudinal grooves) as well as plaque-like adhesions to the hair, likely caused by an abnormal sebum composition also described in a mouse model of FA2H deficiency. Characteristic imaging features of FAHN/SPG35 can be summarized by the 'WHAT' acronym: white matter changes, hypointensity of the globus pallidus, ponto-cerebellar atrophy, and thin corpus callosum. At least three of four imaging features are present in 85% of FA2H mutation carriers. Here, we report the first systematic, large cohort study in FAHN/SPG35 and determine the phenotypic spectrum, define the disease course and identify clinical and imaging biomarkers.

Indexed as

PhenotypeChildCohort StudiesDemyelinating DiseasesFemaleHeredodegenerative Disorders, Nervous SystemHumansMaleMixed Function OxygenasesMutationPedigreeRetrospective StudiesSpastic Paraplegia, Hereditaryfatty acid alpha-hydroxylaseMixed Function OxygenasesFA2HFAHNhereditary spastic paraplegiaimaging biomarkerSPG35

Identifiers

PMID31135052
PMCPMC6536916
OpenAlexW2942251611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.